Senior insider sale
Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$2.33M
21.65K shares
What this filing means
SMITH HUNTER C plans to sell 21.65K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $2.33M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/5/2026ACC: 0001950047-26-000968
Officer· Chief Financial Officer
Since Mar 2026
21.65K
Shares to sell
$2.33M
Approx. market value
18.41K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
2/10/2025
18.41KTotal acquired18.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2025 | Restricted Stock Units N/A | 18.41K | — |
| Total | 18.41K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.25K
Market value
$344.1K
2/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
18.41K
Market value
$1.99M
2/5/2026
Total
Units
21.65K
Value
$2.33M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2026 | 3.25K | $344.1K | — | Completed |
| Planned — Approximate Date | ||||
2/5/2026 | 18.41K | $1.99M | NASDAQ | Planned |
| Total | 21.65K | $2.33M | ||